General Info
Dr. Frank Hensel at HTGF focuses on drug development companies, particularly those in the clinical stage. His professional background includes a Ph.D. in biology and experience as an entrepreneur in a startup developing antibodies for cancer treatment. He has successfully exited companies with deals reaching up to 425 million euros, emphasizing the importance of partnerships in the drug development sector.
Location:
Country: Germany
Industries: Life Sciences, Chemistry, Oncology, Immunology, Metabolic Diseases, Agriculture, Agritech & Animal Health, Food, Nutrition & Personal Care, Pain, Cardiology, Cardiovascular
Investment Regions: EU
Investment Stages: pre-seed, seed
angel-individual
EU
Want to start building warm intros with this investor?
🤖 AI Activity Report
Status: very-active
AI Reasoning: I found a March 25, 2024 exit for Cardior Pharmaceuticals where Dr. Frank Hensel commented, and multiple later sources show involvement in October 2025 with Tubulis (Series C on Oct 15, 2025). The most recent confirmed activity is Oct 15, 2025 for Tubulis (investment/statement), which is less than 6 months before the reference date, indicating very recent activity. The startup mentioned: Cardior Pharmaceuticals (and Tubulis).
Angel activity thresholds:
Low Activity – Only known angel investments more than 12 months ago.
Active – Known angel investments between the last 12 and 6 months.
Very Active – Known angel investments in the last 6 months.
Investor Contact
Team Members
Name
Role
Email
LinkedIn
…
…
…
…
…
Investment Regions Map
loading map…
Similar Investors
Other similar investors:
Latest on X (Twitter)
Access all contact details of Frank Hensel
Gain instant access to partner names, verified emails, LinkedIn profiles, and more—all in one place. Dive into their portfolio founders and their LinkedIn information, so you can quickly start your outreach and look for warm intros.
Add custom tags to your investor cards. Label them by investment stage, industry focus, interest level, or any other criteria you want to stay organized.
Trusted by Founders like You
Find your matching investors using AI